Bayer CropScience Crescita futura
Future criteri di controllo 5/6
Bayer CropScience prevede che gli utili e i ricavi cresceranno rispettivamente di 24.3% e 10.5% all'anno. Si prevede che l'EPS crescerà di 23.2% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 29.7% in 3 anni.
Informazioni chiave
24.3%
Tasso di crescita degli utili
23.2%
Tasso di crescita dell'EPS
| Chemicals crescita degli utili | 22.9% |
| Tasso di crescita dei ricavi | 10.5% |
| Rendimento futuro del capitale proprio | 29.7% |
| Copertura analitica | Good |
| Ultimo aggiornamento | 25 Nov 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
We Think You Can Look Beyond Bayer CropScience's (NSE:BAYERCROP) Lackluster Earnings
Nov 21
Investor Optimism Abounds Bayer CropScience Limited (NSE:BAYERCROP) But Growth Is Lacking
Oct 28Bayer CropScience (NSE:BAYERCROP) Has A Pretty Healthy Balance Sheet
Sep 15Bayer CropScience's (NSE:BAYERCROP) Dividend Will Be ₹35.00
Jul 19Bayer CropScience (NSE:BAYERCROP) Is Due To Pay A Dividend Of ₹35.00
Jul 05Subdued Growth No Barrier To Bayer CropScience Limited (NSE:BAYERCROP) With Shares Advancing 26%
Jun 27Pinning Down Bayer CropScience Limited's (NSE:BAYERCROP) P/E Is Difficult Right Now
May 08Bayer CropScience (NSE:BAYERCROP) Is Investing Its Capital With Increasing Efficiency
Apr 17Bayer CropScience (NSE:BAYERCROP) Seems To Use Debt Quite Sensibly
Mar 27Bayer CropScience Limited's (NSE:BAYERCROP) Shareholders Might Be Looking For Exit
Feb 02Bayer CropScience's (NSE:BAYERCROP) Dividend Will Be Increased To ₹105.00
Nov 06Does Bayer CropScience (NSE:BAYERCROP) Have A Healthy Balance Sheet?
Sep 06Bayer CropScience (NSE:BAYERCROP) Is Increasing Its Dividend To ₹30.00
Jul 30Bayer CropScience (NSE:BAYERCROP) Is Increasing Its Dividend To ₹30.00
Jul 07Does Bayer CropScience (NSE:BAYERCROP) Have A Healthy Balance Sheet?
Mar 17Should You Be Adding Bayer CropScience (NSE:BAYERCROP) To Your Watchlist Today?
Sep 07Bayer CropScience (NSE:BAYERCROP) Will Pay A Dividend Of ₹25.00
Jul 29Bayer CropScience (NSE:BAYERCROP) Has Announced A Dividend Of ₹25.00
Jul 14With EPS Growth And More, Bayer CropScience (NSE:BAYERCROP) Is Interesting
May 19I Built A List Of Growing Companies And Bayer CropScience (NSE:BAYERCROP) Made The Cut
Feb 11Here's Why Bayer CropScience (NSE:BAYERCROP) Can Manage Its Debt Responsibly
Aug 26Shareholders May Not Be So Generous With Bayer CropScience Limited's (NSE:BAYERCROP) CEO Compensation And Here's Why
Aug 05Bayer CropScience's (NSE:BAYERCROP) Dividend Will Be ₹25.00
Jul 09Key Things To Consider Before Buying Bayer CropScience Limited (NSE:BAYERCROP) For Its Dividend
Apr 29Is Now The Time To Put Bayer CropScience (NSE:BAYERCROP) On Your Watchlist?
Mar 20What Type Of Shareholders Own The Most Number of Bayer CropScience Limited (NSE:BAYERCROP) Shares?
Mar 02Bayer CropScience (NSE:BAYERCROP) Shareholders Booked A 56% Gain In The Last Five Years
Jan 31How Does Bayer CropScience Limited (NSE:BAYERCROP) Fare As A Dividend Stock?
Jan 16Are Robust Financials Driving The Recent Rally In Bayer CropScience Limited's (NSE:BAYERCROP) Stock?
Jan 01I Ran A Stock Scan For Earnings Growth And Bayer CropScience (NSE:BAYERCROP) Passed With Ease
Dec 17How Many Bayer CropScience Limited (NSE:BAYERCROP) Shares Do Institutions Own?
Dec 02
Bayer CropScience (NSE:BAYERCROP) Is Growing Earnings But Are They A Good Guide?
Nov 17Should Bayer CropScience (NSE:BAYERCROP) Be Disappointed With Their 60% Profit?
Nov 02Why Bayer CropScience Limited (NSE:BAYERCROP) Is A Dividend Rockstar
Oct 16Bayer CropScience Limited's (NSE:BAYERCROP) P/E Still Appears To Be Reasonable
Sep 28Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 3/31/2027 | 65,917 | 10,167 | 8,091 | 9,552 | 6 |
| 3/31/2026 | 60,725 | 9,382 | 7,049 | 8,705 | 7 |
| 3/31/2025 | 53,505 | 6,215 | 4,546 | 6,798 | 4 |
| 9/30/2024 | 51,152 | 5,796 | 10,252 | 10,753 | N/A |
| 6/30/2024 | 49,948 | 6,662 | N/A | N/A | N/A |
| 3/31/2024 | 51,032 | 7,405 | 9,059 | 9,516 | N/A |
| 12/31/2023 | 52,942 | 8,030 | N/A | N/A | N/A |
| 9/30/2023 | 53,772 | 8,444 | 4,020 | 4,478 | N/A |
| 6/30/2023 | 52,119 | 7,841 | N/A | N/A | N/A |
| 3/31/2023 | 51,397 | 7,582 | 5,320 | 6,093 | N/A |
| 12/31/2022 | 51,205 | 7,524 | N/A | N/A | N/A |
| 9/30/2022 | 50,727 | 7,027 | 3,070 | 3,842 | N/A |
| 6/30/2022 | 49,859 | 6,942 | N/A | N/A | N/A |
| 3/31/2022 | 47,344 | 6,453 | 1,601 | 2,155 | N/A |
| 12/31/2021 | 45,048 | 5,545 | N/A | N/A | N/A |
| 9/30/2021 | 44,329 | 4,246 | 268 | 698 | N/A |
| 6/30/2021 | 44,494 | 4,951 | N/A | N/A | N/A |
| 3/31/2021 | 42,613 | 4,931 | 6,447 | 6,867 | N/A |
| 12/31/2020 | 39,913 | 4,627 | N/A | N/A | N/A |
| 9/30/2020 | 39,271 | 6,457 | 11,553 | 12,052 | N/A |
| 6/30/2020 | 38,918 | 5,909 | N/A | N/A | N/A |
| 3/31/2020 | 36,094 | 4,745 | 6,246 | 6,659 | N/A |
| 12/31/2019 | 29,294 | 2,864 | N/A | N/A | N/A |
| 9/30/2019 | 28,505 | 2,116 | 2,082 | 2,432 | N/A |
| 6/30/2019 | 25,256 | 1,497 | N/A | N/A | N/A |
| 3/31/2019 | 31,754 | 3,371 | 3,726 | 4,328 | N/A |
| 12/31/2018 | 28,639 | 3,045 | N/A | N/A | N/A |
| 9/30/2018 | 27,226 | 2,877 | N/A | N/A | N/A |
| 6/30/2018 | 28,505 | 3,356 | N/A | N/A | N/A |
| 3/31/2018 | 27,167 | 3,001 | N/A | 1,214 | N/A |
| 12/31/2017 | 26,375 | 2,769 | N/A | N/A | N/A |
| 9/30/2017 | 28,203 | 3,030 | N/A | N/A | N/A |
| 6/30/2017 | 26,796 | 2,715 | N/A | N/A | N/A |
| 3/31/2017 | 28,153 | 2,910 | N/A | 1,573 | N/A |
| 12/31/2016 | 40,105 | 3,323 | N/A | N/A | N/A |
| 9/30/2016 | 32,030 | 3,342 | N/A | N/A | N/A |
| 6/30/2016 | 38,027 | 3,215 | N/A | N/A | N/A |
| 3/31/2016 | 27,838 | 3,151 | N/A | 2,065 | N/A |
| 12/31/2015 | 37,919 | 3,278 | N/A | N/A | N/A |
| 9/30/2015 | 38,569 | 3,554 | N/A | N/A | N/A |
| 6/30/2015 | 39,222 | 3,814 | N/A | N/A | N/A |
| 3/31/2015 | 37,233 | 3,830 | N/A | 2,004 | N/A |
| 12/31/2014 | 36,996 | 3,858 | N/A | N/A | N/A |
| 9/30/2014 | 36,390 | 3,698 | N/A | N/A | N/A |
| 6/30/2014 | 34,513 | 3,102 | N/A | N/A | N/A |
| 3/31/2014 | 32,452 | 2,895 | N/A | 2,815 | N/A |
| 12/31/2013 | 30,870 | 3,151 | N/A | N/A | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: La crescita prevista degli utili di BAYERCROP ( 24.3% all'anno) è superiore al tasso di risparmio ( 6.7% ).
Guadagni vs Mercato: Si prevede che gli utili di BAYERCROP ( 24.3% all'anno) cresceranno più rapidamente del mercato Indian ( 17.9% all'anno).
Guadagni ad alta crescita: Si prevede che gli utili di BAYERCROP cresceranno in modo significativo nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di BAYERCROP ( 10.5% all'anno) crescerà più rapidamente del mercato Indian ( 10.5% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di BAYERCROP ( 10.5% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Si prevede che il Return on Equity di BAYERCROP sarà elevato tra 3 anni ( 29.7 %)